The Patent Litigation Europe Summit

Memo

Patent litigation in Europe doesn't stand still, and neither does Patent Litigation Europe. Kisaco Research's flagship legal summit returns to Amsterdam's Beurs van Berlage from 18-20 January 2027, uniting 1,000+ in-house counsel, litigators, judges and policymakers for three days of the sharpest, most commercially relevant patent litigation content on the continent.The event opens with the cross-sector UPC Litigation Forum on Monday 18th January, before splitting into two co-located tracks: Pharma and Biotech Patent Litigation Europe and Tech and Innovation Patent Litigation Europe, running Tuesday 19th to Wednesday 20th January. Whichever room you're in, you're steps away from the conversations happening in the other, with 50% of the audience made up of in-house counsel from the world's most innovative organisations.WHY NOW The Unified Patent Court is no longer a pilot project. As it moves into its fourth year, the court is a globally respected venue, and the questions it raises are increasingly global too: long-arm jurisdiction now reaches into the US, China and non-ratified European states; the Patent Mediation and Arbitration Centre has opened its doors; and a maturing body of Court of Appeal case law is reshaping how every division approaches claim construction, inventive step and preliminary injunctions. Meanwhile, SEP licensing is spreading into new industries, AI-enabled inventions are testing the limits of patentability, and the EU Pharma Package is rewriting the rules on exclusivities and Bolar exemptions. This is the moment to be in the room, particularly with rising court fees and an expanding Court of Appeal changing the calculus for where and how to file.THE UPC LITIGATION FORUM Day one brings the full audience together for keynotes, a judges' panel offering a candid three-years-in review from the bench, and two parallel tracks: UPC Strategy and Case Law, and UPC and Global Litigation Strategy. Expect deep dives into preliminary injunctions post-Insulet v EOFlow, the long-arm jurisdiction debate following BSH v Electrolux, the rise of third-party litigation funding, and how parties are running the UPC alongside EPO oppositions and national courts as a single, coordinated strategy.PHARMA and BIOTECH PATENT LITIGATION EUROPE Innovators, generics, biosimilar, biotech and MedTech companies convene for two days on the issues defining life sciences disputes: cross-border enforcement, method-of-manufacturing claims, preliminary injunctions, settlement strategy, biosimilars litigation, innovator-innovator enforcement, secondary patents, SPCs and the manufacturing waiver, and the EU Pharma Package's implications for exclusivity strategy.TECH and INNOVATION PATENT LITIGATION EUROPE Now in its second year, this track covers the full sweep of technology disputes: SEP and FRAND enforcement, AI-related IP disputes, automotive and connected-vehicle patents, semiconductors, telecoms, consumer electronics and MedTech, plus the NPEs litigating across all of them. Sessions this year go further still, addressing the emerging risks of quantum computing and aggregate rate setting.Both tracks are framed within the global picture, with perspectives from the US, China, Brazil and India on everything from ITC enforcement and safe harbor case law to FRAND rate-setting trends beyond Europe's borders.NEW FOR 2027 This year's agenda adds a run of specialist workshops on trade secrets, transactions, soft IP and MedTech disputes, giving delegates smaller, sharper formats to go deep on the challenges shaping their specific corner of the IP litigation landscape, alongside the main-stage programme.WHO YOU'LL MEET Recent speaking faculty includes senior IP leaders from Nokia, Novartis, Medtronic, Novo Nordisk, Regeneron, ASML, Vodafone, Astellas Pharma, Fresenius Kabi, bioMerieux, HP, Sonos, Autoliv, Umicore and Syngenta, alongside sitting UPC judges, leading private practice litigators and the vendors and consultancies who support them. The room splits roughly evenly between in-house counsel setting strategy, the private practice partners who execute it, and the judges and policymakers writing the rules both sides play by.Whether you're defending your portfolio, enforcing it, or presiding over the disputes that result, you'll leave with offensive and defensive strategy you can put to work immediately, first-hand perspective from every side of the table, and the connections that only three days in the same room can build.Beurs van Berlage puts all of this five minutes from Amsterdam Centraal, with direct connections to Schiphol Airport and the rest of Europe. Add the UPC Litigation Forum to your main event pass, or attend it standalone, and secure your place at the definitive annual gathering for the European patent litigation community, where next year's precedent gets shaped by the conversations you have this January.URLs:Tickets: https://go.evvnt.com/3783625-0?pid=5569Brochure: https://go.evvnt.com/3783625-2?pid=5569Date and Time: On Monday January 18, 2027 at 8:00 am to Wednesday January 20, 2027 at 5:00 pmVenue details: Beurs van Berlage, 243 Damrak, Amsterdam, Noord-Holland, 1012 ZJ, NetherlandsPrices:Tier 1 - In-House Counsel: EUR 499.00,Tier 2 - Private Practice: EUR 2249.00,Tier 3 - Solution Providers: EUR 3499.00,UPC DAY PASS: EUR 1299.00